Search Results Search Sort by RelevanceMost Recent Policy Forum May 2009 Closing the Gap: Finding and Encouraging Physicians Who Will Care for the Underserved Keisa Bennett, MD, MPH, Julie Phillips, MD, MPH, and Bridget Teevan, MS Virtual Mentor. 2009;11(5):390-398. doi: 10.1001/virtualmentor.2009.11.5.pfor1-0905. Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289. Podcast Apr 2024 Author Interview: “How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?” Dr Amy B. Cadwallader joins Ethics Talk to discuss her article, coauthored with Kavitha Nallathambi: “How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?”
Policy Forum May 2009 Closing the Gap: Finding and Encouraging Physicians Who Will Care for the Underserved Keisa Bennett, MD, MPH, Julie Phillips, MD, MPH, and Bridget Teevan, MS Virtual Mentor. 2009;11(5):390-398. doi: 10.1001/virtualmentor.2009.11.5.pfor1-0905.
Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289.
Podcast Apr 2024 Author Interview: “How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?” Dr Amy B. Cadwallader joins Ethics Talk to discuss her article, coauthored with Kavitha Nallathambi: “How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup?”